Search results
Amato and Partners, with years of experience in the capital markets, advised a client through a turbulent early stage, and positioned it for growth. A pharmaceutical company with a clinical-stage cancer drug, the company went public through a reverse merger in March of 2013.
Sep 3, 2019 · Anna Amato, 57, has owned several businesses, employed dozens of people and paid '£500,000 in tax' and is now facing a legal limbo. Fifty five years ago Anna Amato moved with her parents from...
Nov 2, 2010 · Dr Anthony Amato is the vice-chairman of the Department of Neurology and the Director of the Neuromuscular Division and Clinical Neurophysiology Laboratory at Brigham and Women’s Hospital in Boston and a Professor of Neurology at Harvard Medical School.
A Dermatologic Pharmaceutical Company. TESTIMONIALS. “We started with Amato from the beginning of our public life, We were an OTC-listed company and Amato developed our full IR strategy, including orchestrating our capital raises and up-list strategy to NASDAQ.
MD, MRCGP, PGDip General Practitioner with special interest in Acute and Cardiovascular Medicine, Aesthetic Medicine · Experience: NHS · Education: University of South Wales · Location: Dartford...
- 500+
- 586
- NHS
- Dartford, England, United Kingdom
Champion of Emerging Growth Companies in the Capital Markets. Amato and Partners (“Amato”) is an independent boutique Investor Relations and Capital Market Advisory firm headquartered in New York City.
People also ask
Who is Amato and partners?
Who is Dr Amato?
Why did Amato's father move to Britain?
Feb 4, 2018 · Dr. Amato was the co-founder (with Andrew Weil, M.D.) and past chair of the National Integrative Medicine Council. Dr. Amato has worked with the Department of Education to deliver a stress reduction program for elementary school children in the Scranton PA School District.
